Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: CD45BE-HSPC + CART-45 Cells [Phase 1]
Phase 1 study evaluating CD45BE-HSPC with CART-45 cells is not yet recruiting and targets B-cell non-Hodgkin lymphoma and Richter transforma…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Sperm Epigenome in Hodgkin Lymphoma [NA]
This entry notes a clinical trial investigating the sperm epigenome in patients with Hodgkin lymphoma, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes (GRALE) for EBV-positive lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
A clinical trial update notes that a study evaluating therapeutic recommendations for children with Hodgkin lymphoma is currently recruiting…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies [Phase 2]
Phase 2 clinical trial update describing a donor stem cell transplant conditioning regimen with treosulfan, fludarabine, and total-body irra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies [Phase 1, Phase 2]
A first-in-human study evaluating HLA partially to fully matched allogeneic, cryopreserved deceased donor bone marrow transplantation for va…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
An ongoing study by the Children's Oncology Group investigates how patterns of blood cell growth relate to heart health after treatment for …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India [Phase 4]
A Phase 4 clinical trial in India evaluating brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine for adults with Hodgkin lymp…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial update evaluating busulfan, fludarabine phosphate, and post-transplant cyclophosphamide in patients with hematologi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating A(B)VD chemotherapy followed by Nivolumab as frontline therapy for higher-risk classical Hodgkin lymph…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
Update on a clinical study examining myocardial tissue injury and heart function in survivors of Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL [Phase 2]
A Phase II trial evaluating the combination of pembrolizumab and all-trans retinoic acid for relapsed or refractory Hodgkin lymphoma and non…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab plus brentuximab vedotin versus GDP chemotherapy with stem cell transplant for relapsed/re…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Lifestyle Intervention of Food and Exercise for Lymphoma Survivors [NA]
A University of Miami-led clinical trial evaluating a lifestyle intervention involving diet and exercise for lymphoma survivors is currently…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Prognostic Model of Elderly Hodgkin Lymphoma in China
Update on a prognostic model study for elderly Hodgkin Lymphoma patients in China, sponsored by Tianjin Medical University Cancer Institute …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients [Phase 1, Phase 2]
A multicenter Phase 1/2 clinical trial is evaluating the combination of atezolizumab with the BEGEV chemotherapy regimen for relapsed or ref…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Communication Skills Intervention to Promote Transition Into Survivorship
This clinical trial update describes a communication skills intervention intended to help patients with Hodgkin lymphoma and diffuse large B…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors [NA]
A clinical trial update describing a study on implementing lifestyle-based survivorship care plans for lymphoma survivors.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial at Mayo Clinic evaluating low-dose selinexor in combination with choline salicylate for relapsed or refractory Hodgkin lymph…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL [Phase 1]
Phase 1 study of CAR-T cells targeting CD30 and CCR4 for relapsed/refractory CD30+ Hodgkin lymphoma and cutaneous T-cell lymphoma, with the …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL [Phase 1, Phase 2]
Update on a CD30-targeted CAR-T cell therapy being studied for relapsed/refractory Hodgkin lymphoma and CD30+ Non-Hodgkin lymphoma in Phase …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
A clinical trial update focusing on diagnosing PAX5-negative Hodgkin-like lymphomas, highlighting the diagnostic challenges in Hodgkin and n…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma [NA]
This clinical trial update describes a study evaluating clearance of minimal residual disease at the end of first-line treatment in patients…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma [NA]
An ongoing radiation dose study for relapsed/refractory Hodgkin lymphoma and non-Hodgkin lymphoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
A Stanford University–sponsored clinical trial is recruiting to study clinical and pathologic aspects of Non-Hodgkin lymphoma and Hodgkin ly…